NASDAQ: ACAD · Biotechnology
Over the past week, Acadia Pharmaceuticals (ACAD) racked up 10 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 23% bullish but is sharply divided: X runs 50% bullish while Reddit sits at just 0%. Wall Street is more constructive, with 16 of 21 analysts rating ACAD a buy.
There is little buzz around ACAD this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 76% buy share sits next to a crowd that ranges from Reddit at 0% to X at 50%. No other tracker puts the two side by side.
21 analysts have weighed in: a Strong Buy consensus: 16 buy calls against 1 sell, with an average 12-month price target of $32.16.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is improving and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 53 points above the crowd average of 23%, the professionals are more constructive than retail. The split is inside the crowd: X reads 50% bullish while Reddit sits at 0%, a 50-point spread that single-source trackers miss.
Over the 30-day window, Acadia Pharmaceuticals (ACAD) buzz held subdued around 0.0 while the price drifted down 28.8% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 2.3M shares. Updated Oct 03, 2026. Over the last 7 trading days, ACAD lost 10.1%. Buzz activity in the recent week averaged 22.9 and was highly volatile, swinging between 0.0 and 44.3. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bearish on 4 of the 7 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for ACAD and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live ACAD sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 03, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (16 / 4 / 1) |
| Crowd bullish (7d) | 23% |
| Avg price target | $32.16 |
| Most bullish source | X, 50% |
| Most bearish source | Reddit, 0% |
| Sentiment spread | 50 pts |
| Mentions (7d) | 10 |
| Market cap | $3.43B |
| P/E · Forward P/E | 9.0 · 25.2 |
| EPS · Beta | $2.20 · 0.9 |
| Revenue (TTM) | $1.14B · 33% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Acadia Pharmaceuticals (ACAD) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 23% bullish across 3 active sources. Those sources contribute 10 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Acadia Pharmaceuticals (ACAD) is fairly quiet with 1 mentions over the last 7 days; the 30-day context spans 1 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Acadia Pharmaceuticals (ACAD), averaging 23% bullish across 3 tracked sources over the last 7 days. The two ends of the range are X at 50% bullish and Reddit at 0%, a 50-point spread. On the professional side, 16 of 21 analysts rate ACAD a buy.
Of the 21 analysts covering Acadia Pharmaceuticals (ACAD), 16 rate it a buy, 4 a hold and 1 a sell, for a strong buy consensus. The average price target is $32.16. That puts the street ahead of the crowd, which averages 23% bullish.
Acadia Pharmaceuticals (ACAD)'s cross-source average is bearish at 23% bullish. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish. X reads 50% bullish, News reads 20% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Acadia Pharmaceuticals (ACAD) at 23% bullish. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish. The most bearish reading is reddit at 0% bullish. 3-day activity momentum is rising across News. The sell signal carries 93/100 conviction.
News is the dominant discussion channel with 5 mentions (50% of total volume). X contributes 4 mentions and Reddit contributes 1 mention. The cross-source average is bearish at 23% bullish, while news is the only source with rising 3-day activity. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. ACAD's sell signal at 93/100 conviction reflects a bearish cross-source average at 23% bullish. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish. It is a research shortcut, not financial advice.
The ACAD sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key